Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non‐interventional study <scp>MabSCale</scp>-Reference-Cited by-同舟云学术

Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non‐interventional study MabSCale

Published:2022-08-26 Issue:3 Volume:12 Page:2739-2751
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Dürig Jan¹^ORCID,Uhlig Jens²,Gerhardt Anke³,Ritter Markus⁴,Hapke Gunnar⁵,Heßling Jörg⁶,Staib Peter⁷,Wolff Frieder⁸,Krumm Katja⁹,von Weikersthal Ludwig Fischer¹⁰

Affiliation:

1. Department of Hematology University Medicine Essen Essen Germany

2. Oncological Practice Naunhof Germany

3. Medical Care Centre for Blood and Cancer Diseases Potsdam Germany

4. Department of Hematology and Oncology Hospital Sindelfingen‐Böblingen Germany

5. Marienkrankenhaus Hamburg Hamburg Germany

6. Onkologie am Segelfliegerdamm Berlin Germany

7. St.‐Antonius Hospital Eschweiler Germany

8. Roche Pharma AG, Biometrics & Epidemiology Grenzach‐Wyhlen Germany

9. Roche Pharma AG, Department of Hematology Grenzach‐Wyhlen Germany

10. St. Marien Health Centre Amberg Germany

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5160

Reference32 articles.

1. World Health Organization corp‐author.Diffuse large B‐cell lymphoma Union for International Cancer Control. Accessed December 15 2021. Available from:http://www.who.int/selection_medicines/committees/expert/20/applications/DiffuseLargeBCellLymphoma.pdf

2. Lymphoma Research foundation.Diffuse large B‐cell lymphoma. Accessed December 15 2021. Available from:https://lymphoma.org/aboutlymphoma/nhl/dlbcl/

3. LenzG ChapuyB Glaß B et al.Diffuses großzelliges B‐Zell‐Lymphom Onkopedia Leitlinie [German]. Accessed December 15 2021. Available from:https://www.onkopedia.com/de/onkopedia/guidelines/diffuses‐grosszelliges‐b‐zell‐lymphom/@@guideline/html/index.html

4. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

5. Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Developments in Convenience of Administration of the Anti-CD38 Antibody Isatuximab: Subcutaneous Delivery and Fast Intravenous Infusion in Patients With Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2024-06

2. Clinical efficacy and safety of subcutaneous rituximab in non-Hodgkin lymphoma: a systematic literature review and meta-analysis;Hematology;2023-11-27